Please join us for our next KRYPTON seminar of the Fall 2021 semester. We will meet at the usual time, 1600h, on Friday October
29, 2021.
We will continue to have a virtual option, but will also meet in Room 2214 ENGR for those who want to attend in person. I will be
traveling and will try to call in from the airport before boarding my plane. Dr. Hadi El-Amine will attend in person in Room 2241 ENGR.
You can check Krypton events through our calendar at:
[log in to unmask]&ctz=America/New_York&pli=1" class="">https:[log in to unmask]&ctz=America/New_York&pli=1
**********************************************
Krypton Seminar Series - Fall 2021
Date: October 29, 2021
Time: 4:00PM - 5:30PM
Venue: Zoom and Room 2241 ENGR
Link for remote participation: https://gmu.zoom.us/j/92356938266
***********************************************
Marwan Shams Eddin
PhD student, Systems Engineering and Operations Research, GMU
***********************************************
Title — Large-scale Infectious Disease Screening in Dynamic and Variable Environments
Abstract — In this work we focus on large-scale infectious disease
screening in dynamic and highly variable environments. Large-scale screening is crucial to any well-functioning healthcare system as it has direct impact on human life as was demonstrated in the ongoing COVID -19 pandemic. Problems that arise in this context
are often sequential as they involve taking screening actions, observing outcomes (which are often affected by uncertainty), and then adjusting decision accordingly. Given the nature of the problems involved, decision that are more conservative (as opposed
to ones that rely on average-case performance) are desirable. Therefore, we rely on tools such as robust dynamic programming and optimal control to solve the resulting sequential decision-making problems. We focus on two aspects of the problem. The first deals
with large-scale screening of established infections in which disease evolution can be predicted with a fairly good level of accuracy. In this setting, screening policies do not have a substantial impact on disease prevalence in the short-to-medium term and
thus interactions between screening and populations characteristics can be relaxed. The second aspect focuses on large-scale screening for emerging pandemics. In this setting, modeling the interaction between screening decisions and disease dynamics on the short-term
is crucial and thus must be explicitly incorporated in the decision-making framework. This unfortunately complicates the problem from a modeling perspective. For both problem aspects, we propose efficient algorithms and present case studies in the context of
large-scale screening of donated blood in blood centers and of COVID-19 in the U.S.